Actinium Pharmaceuticals Stock Market Value
| ATNM Stock | USD 1.25 0.03 2.34% |
| Symbol | Actinium |
Actinium Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Actinium Pharmaceuticals. If investors know Actinium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Actinium Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.36) | Revenue Per Share 0.003 | Quarterly Revenue Growth (1.00) | Return On Assets (0.31) | Return On Equity (0.88) |
The market value of Actinium Pharmaceuticals is measured differently than its book value, which is the value of Actinium that is recorded on the company's balance sheet. Investors also form their own opinion of Actinium Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Actinium Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Actinium Pharmaceuticals' market value can be influenced by many factors that don't directly affect Actinium Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Actinium Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Actinium Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Actinium Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Actinium Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Actinium Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Actinium Pharmaceuticals.
| 12/24/2022 |
| 12/13/2024 |
If you would invest 0.00 in Actinium Pharmaceuticals on December 24, 2022 and sell it all today you would earn a total of 0.00 from holding Actinium Pharmaceuticals or generate 0.0% return on investment in Actinium Pharmaceuticals over 720 days. Actinium Pharmaceuticals is related to or competes with Mink Therapeutics, Affimed NV, Adaptimmune Therapeutics, Sangamo Therapeutics, Rigel Pharmaceuticals, Fortress Biotech, and Reviva Pharmaceuticals. Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing th... More
Actinium Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Actinium Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Actinium Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 20.13 | |||
| Value At Risk | (6.74) | |||
| Potential Upside | 6.82 |
Actinium Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Actinium Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Actinium Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Actinium Pharmaceuticals historical prices to predict the future Actinium Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.76) | |||
| Total Risk Alpha | (1.21) | |||
| Treynor Ratio | (0.33) |
Actinium Pharmaceuticals Backtested Returns
Actinium Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0997, which signifies that the company had a -0.0997% return per unit of risk over the last 3 months. Actinium Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Actinium Pharmaceuticals' Mean Deviation of 3.53, risk adjusted performance of (0.08), and Standard Deviation of 4.48 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.75, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Actinium Pharmaceuticals will likely underperform. At this point, Actinium Pharmaceuticals has a negative expected return of -0.45%. Please make sure to confirm Actinium Pharmaceuticals' total risk alpha, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Actinium Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.59 |
Modest predictability
Actinium Pharmaceuticals has modest predictability. Overlapping area represents the amount of predictability between Actinium Pharmaceuticals time series from 24th of December 2022 to 19th of December 2023 and 19th of December 2023 to 13th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Actinium Pharmaceuticals price movement. The serial correlation of 0.59 indicates that roughly 59.0% of current Actinium Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.59 | |
| Spearman Rank Test | 0.59 | |
| Residual Average | 0.0 | |
| Price Variance | 8.09 |
Actinium Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Actinium Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Actinium Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Actinium Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Actinium Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Actinium Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Actinium Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Actinium Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Actinium Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Actinium Pharmaceuticals Lagged Returns
When evaluating Actinium Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Actinium Pharmaceuticals stock have on its future price. Actinium Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Actinium Pharmaceuticals autocorrelation shows the relationship between Actinium Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Actinium Pharmaceuticals.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Actinium Pharmaceuticals Correlation, Actinium Pharmaceuticals Volatility and Actinium Pharmaceuticals Alpha and Beta module to complement your research on Actinium Pharmaceuticals. To learn how to invest in Actinium Stock, please use our How to Invest in Actinium Pharmaceuticals guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Actinium Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.